Drugs / ethyl pyruvate
ethyl pyruvate
also known as
2-oxo-propionic acid ethyl ester · CTI-01 · FEMA NO. 2457 · NSC-48386 · Pyruvic acid ethyl ester
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00107666 | Apr 2005 → Apr 2006 | coronary artery disorder, heart valve disorder | Critical Therapeutics | Terminated | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT01712295 | Nov 2011 → Dec 2013 | plantar wart | Grossman, Michael, D.P.M. | Unknown | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ethyl pyruvate | “CTI-01 (ethyl pyruvate)” NCT00107666 ↗ |
| Known as | 2-oxo-propionic acid ethyl ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL173373 ↗ |
| Known as | CTI-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00107666 ↗ |
| Known as | FEMA NO. 2457 | ChEMBL registry synonym — accepted as the source's own label CHEMBL173373 ↗ |
| Known as | NSC-48386 | ChEMBL registry synonym — accepted as the source's own label CHEMBL173373 ↗ |
| Known as | Pyruvic acid ethyl ester | ChEMBL registry synonym — accepted as the source's own label CHEMBL173373 ↗ |
| Modality | Small molecule | — CHEMBL173373 ↗ |
| Route | Intravenous | “administered intravenously just prior to and after surgery” NCT00107666 ↗ |